Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03930654 · ClinicalTrials.gov registry record · NA
Leveraging the Emergency Department to Engage African American Women in HIV Pre-Exposure Prophylaxis
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03930654 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 40 participants.
The verdict
NCT03930654, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
African American (AA) women are more vulnerable to HIV infection than other women. Truvada, when used as pre-exposure prophylaxis (PrEP), is one of the most effective approaches for HIV prevention; however, PrEP use among AA women remains low and has not responded to traditional interventions. This study proposes for the first time an innovative computer-based motivational intervention, increasing PrEP uptake (iPrEP), which couples motivational messages woven into a traditional survey to raise awareness of risky sex and substance use behaviors.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL iPrEP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-11-13 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03930654
The ClinicalTrials.gov registry entry for NCT03930654 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT03930654 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03930654 about?
NCT03930654 is a clinical study titled "Leveraging the Emergency Department to Engage African American Women in HIV Pre-Exposure Prophylaxis". African American (AA) women are more vulnerable to HIV infection than other women. Truvada, when used as pre-exposure prophylaxis (PrEP), is one of the most effective approaches for HIV prevention; however, PrEP use among AA women remains low and has not responded to traditional interventions. This ...
What is the current status of trial NCT03930654?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-11-13. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03930654?
The interventions under investigation include: Usual Care (BEHAVIORAL), iPrEP (BEHAVIORAL).
Who is sponsoring clinical trial NCT03930654?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.